DJIA 16,943.81 28.74 0.17%
NASDAQ 4,415.49 19.29 0.44%
S&P 500 1,967.57 2.89 0.15%
market minute promo

316.11 1.62 (0.52%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $316.11 0.52%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $314.98
Previous Close $314.49
Daily Range $310.75 - $318.87
52-Week Range $227.64 - $352.49
Market Cap $31.9B
P/E Ratio 90.11
Dividend (Yield) $0.00 (0.0%)
Volume 954,740
Average Daily Volume 911,849
Current FY EPS $9.29

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary Rss Feed

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

Sanofi/Regeneron Announce Encouraging Dupilumab Data - Analyst Blog

UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Following Good Results Of Drug Study

Cramer: Valeant Is Hard to Stop

Benzinga's Top #PreMarket Gainers

Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14)

Jim Cramer's Top Stock Picks: WMB AA BIIB REGN CELG GILD UNUM

UPDATE: Regeneron, Sanofi Offer Positive Results from Phase 2b Study of Dupilum, All Doses Met Prima

UPDATE: Regeneron, Sanofi Offer Positive Results from Phase 2b Study of Dupilum, All Doses Met Primary Endpoint

Anacor's Kerydin Gets FDA Nod for Onychomycosis - Analyst Blog

5 Stocks Insiders Love Right Now

Sanofi buys big chunk of Regeneron shares

See More REGN News...

REGN's Top Competitors

REGN $316.11 (0.52%)
Current stock: REGN
AMGN $119.77 (0.69%)
Current stock: AMGN
GILD $88.73 (-0.24%)
Current stock: GILD
BIIB $322.22 (0.97%)
Current stock: BIIB